Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CILAZAPRIL | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 80 |
| APO-CILAZAPRIL | 2.5MG | TABLET | Resolved | 2020-03-04 | 2020-05-15 | 107693 |
| APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2020-03-04 | 2020-05-15 | 107711 |
| APO-CILAZAPRIL | 2.5MG | TABLET | Resolved | 2020-06-10 | 2020-09-14 | 117377 |
| APO-CILAZAPRIL | 5MG | TABLET | Resolved | 2021-12-24 | 2022-04-04 | 151883 |
| APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2018-01-03 | 2018-08-18 | 34841 |
| APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2023-11-24 | 2023-12-01 | 211496 |
| APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2022-12-05 | 2023-02-02 | 177115 |
| APO-CILAZAPRIL/HCTZ | 12.5MG 5MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 83 |
| APO-CIMETIDINE ORAL SOLUTION | 300MG | LIQUID | Actual shortage | 2017-08-13 | 2017-10-05 | 19102 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2023-09-07 | 2023-10-15 | 203809 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2020-10-14 | 2020-12-21 | 126274 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2020-10-28 | 2020-12-21 | 127331 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2021-02-26 | 2021-03-24 | 134802 |
| APO-CINACALCET | 90MG | TABLET | Resolved | 2018-05-08 | 2018-11-23 | 48835 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2018-08-09 | 2018-11-23 | 57775 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2018-01-31 | 2018-11-23 | 37726 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2019-05-15 | 2019-06-01 | 84118 |
| APO-CINACALCET | 30MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 86 |
| APO-CINACALCET | 90MG | TABLET | Resolved | 2022-09-09 | 2022-10-07 | 169051 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-10 | 2018-12-28 | 60997 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
| APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
| APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
| APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
| APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
| APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60637 |
| APO-MYCOPHENOLATE | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60640 |
| APO-NAPRO-NA | 275MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60657 |
| APO-NAPRO-NA DS | 550MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60660 |
| APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
| APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |